Microstructural analysis and bioactive response of selectively engineered glass-ceramics in simulated body fluid
Source abstract
Abstract
This study reports development of engineered fluorcanasite frankemenite-fluorapatite glass-ceramic materials for potential bone scaffold applications. A systematic approach was undertaken to selectively tune the glass compositions and process parameters towards developing bone mimicking crystalline microstructure and enhancement of bioactive response. Differential thermal analysis was performed to design a controlled two stage heat treatment profile to convert the synthesized glass compositions into glass-ceramics. X-ray diffraction studies confirmed the presence of fluorcanasite, frankamenite and fluorapatite as the predominant phases, where fluorapatite is anticipated to induce enhanced bioactivity. Scanning electron microscopy of the fractured glass-ceramics revealed interpenetrating lath like microstructure, responsible for mechanical interlocking of crystalline phases. Systematic pH study of the glass-ceramic candidates carried out in simulated body fluid (SBF) recorded initial increase followed by stable pH values, confirming bioactivity and minimal leaching. The results from our study therefore, establishes the promising potential of the novel glass-ceramic biomaterials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Facial Trauma and Fracture Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Mechanical Engineering, Manipal University Jaipur, Jaipur, India
Funding
Science and Engineering Research Board
References (28)
Show source-provided references
1. 10.1016/B978-0-08-102451-5.00006-810.1016/B978-0-08-102451-5.00006-8 ↗
2. 10.1016/j.ceramint.2019.07.09610.1016/j.ceramint.2019.07.096 ↗
3. 10.1002/jbm.1001810.1002/jbm.10018 ↗
4. 10.1023/A:102677352293410.1023/A:1026773522934 ↗
5. 10.1002/jbm.a.3566410.1002/jbm.a.35664 ↗
6. 10.1007/s11837-009-0131-610.1007/s11837-009-0131-6 ↗
7. 10.3390/ijms2003072210.3390/ijms20030722 ↗
8. 10.1016/0142-9612(95)00356-810.1016/0142-9612(95)00356-8 ↗
9. 10.1016/j.msec.2019.10989510.1016/j.msec.2019.109895 ↗
10. Majhi MR · J Biomimetics Biomater Biomed Eng · 2011 · 11 · 45
11. 10.1016/j.actbio.2008.11.02510.1016/j.actbio.2008.11.025 ↗
12. 10.1080/10667857.2016.122460910.1080/10667857.2016.1224609 ↗
13. 10.2109/jcersj.99.110.2109/jcersj.99.1 ↗
14. 10.1111/j.1551-2916.2005.00589.x10.1111/j.1551-2916.2005.00589.x ↗
15. Reaney IM · J Biomed Mater Res · 2006 · 80 · 175
16. Faria PEP · J Biomed Mater Res · 2010 · 94 · 760
17. 10.1111/j.1151-2916.1995.tb08887.x10.1111/j.1151-2916.1995.tb08887.x ↗
18. 10.1016/j.polymdegradstab.2019.04.01710.1016/j.polymdegradstab.2019.04.017 ↗
19. 10.1002/1521-4079(200211)37:11<1165::AID-CRAT1165>3.0.CO;2-R10.1002/1521-4079(200211)37:11<1165::AID-CRAT1165>3.0.CO;2-R ↗
20. 10.1111/j.1151-2916.1995.tb08677.x10.1111/j.1151-2916.1995.tb08677.x ↗
21. 10.1016/j.jas.2012.07.00810.1016/j.jas.2012.07.008 ↗
22. 10.1016/j.jas.2014.05.00410.1016/j.jas.2014.05.004 ↗
23. 10.1016/j.ceramint.2006.04.00110.1016/j.ceramint.2006.04.001 ↗
24. 10.1016/S0022-3093(01)00822-510.1016/S0022-3093(01)00822-5 ↗
25. 10.1007/BF0036966110.1007/BF00369661 ↗
26. 10.1002/(SICI)1097-4636(199604)30:4<509::AID-JBM9>3.0.CO;2-T10.1002/(SICI)1097-4636(199604)30:4<509::AID-JBM9>3.0.CO;2-T ↗
27. 10.1016/j.actbio.2005.11.00110.1016/j.actbio.2005.11.001 ↗
28. Bandyopadhyay-ghosh S · Trends Biomater Artif Organs · 2008 · 22 · 116